Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study - Full Text View

Sponsors and Collaborators:	Harvard Pilgrim Health Care American Diabetes Association
Information provided by:	Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier:	NCT00790530

Purpose

The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.

Condition	Intervention
Diabetes Mellitus	Behavioral: Automated Telephone Outreach with Speech Recognition Other: Usual Care

Study Type:	Interventional
Study Design:	Health Services Research, Randomized, Open Label, Parallel Assignment
Official Title:	Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study

Resource links provided by NLM:

MedlinePlus related topics: Diabetes

U.S. FDA Resources

Further study details as provided by Harvard Pilgrim Health Care:

Primary Outcome Measures:

Completion of dilated eye examination [ Time Frame: 12-months following intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Completion of glycated hemoglobin testing (HbA1c) [ Time Frame: one-year following intervention ] [ Designated as safety issue: No ]
Completion of LDL-cholesterol testing [ Time Frame: one year following intervention ] [ Designated as safety issue: No ]
Completion of microalbumin testing [ Time Frame: one-year following intervention ] [ Designated as safety issue: No ]

Enrollment:	1200
Study Start Date:	June 2006
Study Completion Date:	October 2007
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
ATO-SR: Experimental Automated Telephone Outreach with Speech Recognition	Behavioral: Automated Telephone Outreach with Speech Recognition Automated Telephone Outreach with Speech Recognition
Usual Care: No Intervention Usual Care	Other: Usual Care Usual Care

Detailed Description:

Randomly allocate a total of 1200 health plan members with diabetes to automated telephone outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention is a series of three calls, using automated calls, originating from the health plan, using interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage participants to fulfill the recommended testing (dilated eye examinations, glycated hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the preceding year.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Age 18 years or older
Diabetes, defined as either 1) filled a prescription for insulin or an oral hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients encounter claims with an ICD9-CM or CPT code indicating diabetes.
Gap in a key diabetes management metric as evidenced by no claim for a dilated eye examination in the prior 15 months and no claim for one or more of the following tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with evidence of having received ACE-inhibitors or angiotensin receptor blockers were considered to have had a microalbumin test.)

Exclusion Criteria:

No primary care clinician in the data base
Those who had previously asked the health plan to exclude them from research or quality improvement
Women whose claim records contained diagnoses suggesting gestational diabetes

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00790530

Locations

United States, Massachusetts
Harvard Pilgrim Health Care
Boston, Massachusetts, United States, 02215

Sponsors and Collaborators

Harvard Pilgrim Health Care

American Diabetes Association

Investigators

Principal Investigator:

Steven R Simon, MD

Harvard Pilgrim Health Care

More Information

No publications provided

Responsible Party:	Harvard Pilgrim Health Care ( Steven R. Simon, Principal Investigator )
Study ID Numbers:	1-05-JF-40
Study First Received:	November 11, 2008
Last Updated:	November 11, 2008
ClinicalTrials.gov Identifier:	NCT00790530 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Harvard Pilgrim Health Care:

Diabetes
Information Technology
Health Plans

Study placed in the following topic categories:

Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases

Endocrinopathy
Glucose Metabolism Disorders
Metabolic Disorder

Additional relevant MeSH terms:

Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on September 10, 2009